-
1
-
2
PREDICTION OF METASTATIC DAMAGE OF REGIONAL LYMPHATIC NODES IN PATIENTS WITH BREAST CANCER
Published 2017-06-01Get full text
Article -
3
Diagnostic value of ICG for sentinel lymph node mapping in patients with stage I endometrial cancer
Published 2024-01-01Get full text
Article -
4
-
5
-
6
-
7
Improved diagnostics of “concealed” metastases in patients with сТ1–2N0М0 oral squamous cell carcinoma
Published 2022-04-01Get full text
Article -
8
THE RELATIONSHIP BETWEEN LYMPHEDEMA AFTER AXILLARY DISSECTION FOR MALIGNANT SKIN TUMORS OF UPPER EXTREMITY AND NUMBER OF LYMPH NODES REMOVED
Published 2024-03-01“…The study examined the number of lymph nodes removed in the dissection materials to evaluate the factors that may predict the development of lymphedema. …”
Get full text
Article -
9
-
10
-
11
-
12
-
13
Clinical Case of Successful Surgical Treatment for Giant Cell Metastatic Lung Sarcoma
Published 2022-10-01Get full text
Article -
14
-
15
CAUSES OF GASTRIC CANCER RECURRENCES IN PATIENTS AFTER RADICAL SURGERY
Published 2019-02-01Get full text
Article -
16
Primary operable breast cancer: molecular subtypes and morphological prognostic factors
Published 2019-06-01Get full text
Article -
17
Recurrence and local lymphogenic metastasis of conjunctival melanoma
Published 2017-04-01Get full text
Article -
18
Consensus process to agree upon surgical quality assurance processes within a pragmatic, multicentre randomised clinical trial comparing targeted axillary dissection and axillary n...
Published 2025-06-01“…Evidence that this highly morbid procedure improves survival is lacking, but approximately 30% of patients will develop lifelong complications which significantly impact their quality of life.Targeted axillary dissection (TAD) may be a safe, less morbid alternative to ANC and will be evaluated in the upcoming Targeted Axillary Dissection versus axillary node clearance in patients with POsitive axillary Lymph nodes in Early breast cancer (TADPOLE) randomised controlled trial.TAD is not currently routine practice in patients having primary surgery, so it is vital that the procedure is performed in an agreed upon, standardised way within the trial and procedure fidelity monitored to ensure the results are generalisable and will be accepted by the surgical community. …”
Get full text
Article -
19
-
20
α-GalCer-LNP ehanced mRNA delivery and activates natural killer T cells for superior tumor immunotherapy
Published 2025-06-01Get full text
Article